{
  "document_id": "HOUSE_OVERSIGHT_028415",
  "filename": "IMAGES-009-HOUSE_OVERSIGHT_028415.txt",
  "text": "2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical\ncompany he led until stepping down to run for United States Senate. To his right are\nRepresentative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel\nEvans/Associated\n\nPress\"},\"identifier\":\"100000006098011 Sba8b80411187\", \"imageIdentifier\":\"el26e7bde26613f\n50f2609cb8776d827\", \"layout\": \"fullbleed-\nimage\", \"role\":\"photo\", \"type\":\"scalable image\"}, {\"identifier\":\" anf-caption-\n\n1\",\"inlineTextStyles\": [{\"range\":{\"length\":27, \"start \":261},\"textStyle\":\"photo-\ncredit\"}],\"layout\":\"default-caption\", \"role\": \"caption\", \"text\":\"Bob Hugin spoke in 2014\nat a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical company\nhe led until stepping down to run for United States Senate. To his right are\nRepresentative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel\n\nEvans/Associated Press \",\"type™:\"text\"}],\"identifier\":\" anf-container-\n5\",\"layout\"™:\"image-\ncontainer\", \"role\":\"container\", \"type\": \"container\"}],\"identifier\":\" anf-section-\n\n2\",\"layout\":\"default-\n\nsection\", \"role\":\"section\", \"scene\": {\"fadeColor\":\"#FFFFFF\",\"type\":\"fading sticky header\"}\n,\"type™:\"section\"}, {\"additions\": [{\"URL\":\"https://www.businesswire.com/news/home/2018012\n9005762/en/Celgene-Announces-Retirement-Executive-Chairman-Bob-\n\nHugin\", \"range\": {\"length\":34, \"start \":194},\"type\":\"link\"}],\"identifier\":\" anf-body-\n6\", \"inlineTextStyles\":[{\"range\": {\"length\":363,\"start\":0},\"textstyle\":\" anf-ts-\nI\"}, {\"range\"™: {\"length\":363,\"start\":0},\"textStyle\":\"_anf-ts-1\"}],\"layout\":\"default—\n\nbody\", \"role\":\"body\", \"text\":\"When Bob Hugin joined Celgene in 1999 as its chief\nfinancial officer, the company was a struggling biotech that sold just one product ae\"\na leprosy drug 4€\" and faced a shaky future. By the time he stepped down as executive\nchairman in February to run for United States Senate, Celgene had become a\npharmaceutical powerhouse with a market value of nearly $80\nbillion.\",\"type\":\"text\"}, {\"additions\": [{\"URL\":\"https://ir.celgene.com/press-\nreleases/press-release-details/2018/Celgene-Reports-Fourth-Quarter-and-Full-Year-2017\nOperating-and-Financial-\nResults/default.aspx\", \"range\": {\"length\":17, \"start \":177},\"type™:\"Link\"}],\"identifier™:\"\nanf-body-7\",\"inlineTextStyles\": [{\"range\"™: {\"length\":195,\"start\":0},\"textStyle\":\" anf-ts-\ni\"}, {\"range™: {\"length\":195,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default-\nbody\", \"role\":\"body\", \"text\":\"And that onetime leprosy drug? It had been transformed into\nRevlimid, a best-selling cancer drug that, with annual sales of $8.2 billion, made up\nnearly two-thirds of Celgened€™s net sales in\n2017.\",\"type™:\"text\"}, {\"additions\"™: [{\"URL\":\"https://youtu.be/K4Agl kLfs5w\", \"range\": {\"len\n\ngth\":34,\"start\":174},\"type\"™:\"link\"}],\"identifier\":\" anf-body-\n\n8\", \"inlineTextstyles\": [{\"range\"<:{\"length\":324,\"start\":0},\"textstyle\":\" anf-ts-—\nI\"}, {\"range™: {\"length\":324,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default—\nbody\", \"role\": \"body\", \"text\":\"Mr. Hugin, a Republican mounting a surprisingly strong\n\nchallenge to Senator Robert Menendez in New Jersey, has made his career at Celgene a\ncornerstone of his campaign, with television advertisements boasting that he d€cechose a\nlife of serviced€ in the Marines and a€eleading a health care company that develops\n\ncancer medicine.a€\", \"type\": \"text\"}, {\"identifier\":\" anf-body-\n9\",\"inlineTextStyles\":[{\"range\": {\"length\":299,\"start\":0},\"textsStyle\":\" anf-ts-\ni\"},{\"range™: {\"length\":299,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default-\n\nbody\", \"role\": \"body\", \"text\":\"In deeply blue New Jersey, few expected a real contest for\nMr. Menendezad€™s seat. Yet anger stemming from Mr. Menendeza€™s federal corruption\ntrial last year 4€\" a trial that Mr. Hugindé€™s campaign reminds television viewers in\nNew Jersey about on a regular basis a4€\" has dampened his popularity among\n\nvoters.\",\"type\":\"text\"}, {\"bannerType\"™: \"any\", \"identifier\":\" anf-banner advertisement\ni\", \"layout\": \"ComponentLayout-—\n4\",\"role\":\"banner advertisement\", \"type\":\"banner advertisement\"}, {\"additions\": [{\"URL™:\"h\n\nttps://twitter.com/realDonaldTrump/status/1016368503723577344\", \"range\": {\"length\":21,\"st\nart ™:213}, \"type™:\"link\"}, {\"URL\":\"https://news.gallup.com/poll1/12748/business-industry-\nsector-\n\nratings.aspx\", \"range\": {\"length\":16, \"start \":238},\"type\"™:\"link\"}],\"identifier\":\" anf-\nbody-10\", \"inlineTextStyles\": [{\"range\"™: {\"length\":413,\"start\":0},\"textStyle\":\" anf-ts-\nI\"}, {\"range\"™: {\"length\":413,\"start\":0},\"textStyle\":\" anf-ts-1\"}],\"layout\":\"default—\nbody\", \"role\": \"body\", \"text\": \"But Mr. Hugind€™s professional career could also prove to\n\nbe a liability da4€\" he is the sole pharmaceutical executive running for statewide office\nin 2018. Anger over high drug prices has risen and President Trump has vilified the\nindustry. A 2017 Gallup poll found that just 33 percent of the country had a favorable\n\nview of the drug industry, the second-lowest of any sector. (The lowest was the federal\ngovernment.)\",\"type\":\"text\"}, {\"identifier\":\" anf-body-\n11i\",\"inlineTextStyles\": [{\"range\":{\"length\":394,\"start\":0},\"textStyle\":\" anf-ts-\n\nHOUSE_OVERSIGHT_028415",
  "metadata": {
    "original_filename": "IMAGES-009-HOUSE_OVERSIGHT_028415.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 5164,
    "word_count": 504,
    "line_count": 86,
    "import_date": "2025-11-19T21:47:45.988921",
    "prefix": "IMAGES-009"
  }
}